Firm
Lawyers at Simmons & Simmons look ahead to a UK Supreme Court hearing in which the court will consider whether English courts can determine FRAND terms when the licence is offered by an intermediary rather than an SEP owner
Firm says appointment of Jeremy Drew from RPC will help create ‘unrivalled IP powerhouse’, as it looks to shore up IP offering ahead of merger
Law firms are expanding their ITC practices to account for the venue’s growing popularity, and some are seeing an opportunity to collaborate with M&A teams
Erise IP has added a seven-practitioner trademark team from Hovey Williams, signalling its intention to help clients at all stages of development
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyAs an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry -
Sponsored by Tilleke & GibbinsSuebsiri Taweepon of Tilleke & Gibbins highlights a critical issue in Thailand’s copyright regime while examining the legal uncertainties, licensing burdens, and data-scraping risks in AI development
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris says the decision on the ‘Belvedere Mykonos Club’ mark highlights the importance of complementary goods and services as a factor in opposition cases
-
Sponsored by Cabinet M OproiuIn this opening article of a series, Raluca Vasilescu of Cabinet M Oproiu explains her conclusions after experimenting with various AI assistants when responding to office actions in patent applications
-
Sponsored by Remfry & SagarSonal Goel of Remfry & Sagar says two recent rulings show Indian courts’ evolving approach to tackling online counterfeiting, impersonation, and trademark misuse through dynamic, dynamic+, and superlative injunctions
-
Sponsored by Bugnion SpAAndrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes
